Blog

BRIEF-Compugen Ltd – Bayer Plans To Advance Cancer Immunotherapy Program Into First-In-Human Trials In 2018 – Reuters

BRIEF-Compugen Ltd – Bayer Plans To Advance Cancer Immunotherapy Program Into First-In-Human Trials In 2018
Reuters
BRIEF-Compugen Ltd – Bayer Plans To Advance Cancer Immunotherapy Program Into First-In-Human Trials In 2018. Reuters Staff. 1 Min Read. April 17 (Reuters) – Compugen Ltd: * COMPUGEN LTD – BAYER PLANS TO ADVANCE CANCER IMMUNOTHERAPY PROGRAM INTO FIRST

2018-04-17 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.